DrugPatentWatch Database Preview
LEVO-T Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Levo-t, and when can generic versions of Levo-t launch?
This drug has eight patent family members in seven countries.
The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
Summary for LEVO-T
| International Patents: | 8 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 16 |
| Bulk Api Vendors: | 129 |
| Patent Applications: | 4,265 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LEVO-T at DailyMed |
Pharmacology for LEVO-T
| Ingredient-type | Thyroxine |
| Drug Class | l-Thyroxine |
Synonyms for LEVO-T
| (-)-Thyroxine |
| (-)-Thyroxine Sodium |
| (125I)T4 |
| (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid |
| (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic aci d, sodium salt |
| (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid |
| (S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid |
| (S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionic Acid Sodium Salt |
| 002T595 |
| 054I36CPMN |
| 137-53-1 |
| 1hk1 |
| 1hk2 |
| 1hk3 |
| 1hk4 |
| 1hk5 |
| 1y0x |
| 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid |
| 24486-40-6 |
| 25416-65-3 |
| 2ceo |
| 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine |
| 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine |
| 3,3?,5,5?-Tetraiodo-L-thyronine sodium salt |
| 3,3',5,5'-Tetraiodo-L-thyronine |
| 3,3',5,5'-Tetraiodo-L-thyronine Sodium |
| 3,3',5,5'-Tetraiodo-L-thyronine sodium salt |
| 3,3',5,5'-Tetraiodo-L-thyronine, sodium salt |
| 3,3',5,5''-Tetraiodo-L-thyronine |
| 3,3',5,5"-Tetraiodo-L-thyronine |
| 3,3'',5,5''-tetraiodo-L-thyronine |
| 3,5,3',5'-Tetraiodo-L-thyronine |
| 3,5,3',5'-Tetraiodothyronine |
| 3,5,3'',5''-tetraiodo-L-thyronine |
| 3,5,3'5'-Tetraiodo-L-thyronine |
| 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine |
| 50809-32-0 |
| 51-48-9 |
| 55-03-8 |
| 587-29-1 |
| 587-30-4 |
| 60833-83-2 |
| 6260AF |
| 67809-22-7 |
| 7200-84-2 |
| 74-16-8 |
| 7488-70-2 |
| 7U4LEE5872 |
| A830452 |
| AB00052176_09 |
| AB00052176_10 |
| AB00052176-08 |
| AB0010528 |
| AB2000689 |
| AC-10210 |
| AC-10465 |
| AC-7504 |
| AC-919 |
| AC1L1L7K |
| AK-40208 |
| AK-46618 |
| AKOS015905129 |
| AKOS015918420 |
| AKOS024284731 |
| AM006672 |
| AM016770 |
| AM83594 |
| AN-15421 |
| AN-8921 |
| API0007805 |
| AX8015809 |
| BBC/815 |
| BC204258 |
| BC630681 |
| BDBM50301375 |
| Berlthyrox |
| beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine |
| BIDD:PXR0161 |
| bmse000923 |
| BPBio1_000360 |
| BRD-K30685142-001-05-5 |
| BRN 2228515 |
| BSPBio_000326 |
| BSPBio_002142 |
| C01829 |
| C08212 |
| C15H10I4NO4.Na |
| C15H11I4NO4 |
| CAS-51-48-9 |
| CCG-38738 |
| CCRIS 6739 |
| CHEBI:18332 |
| CHEBI:6446 |
| CHEMBL1624 |
| CHM0030272 |
| CPD000059176 |
| CS-1819 |
| CT-230 |
| CT-452 |
| CTK2H7538 |
| CTK4J3191 |
| D-3,5-Diiodo-4-(3',5'-Diiodo-4'-hydroxyphenoxy)-phenylalanine sodium salt |
| D06RGG |
| D08125 |
| Dathroid |
| DB-006261 |
| DB00451 |
| DivK1c_006967 |
| DL-Thyroxin |
| DSSTox_CID_3214 |
| DSSTox_GSID_23214 |
| DSSTox_RID_76927 |
| DTXSID8023214 |
| EBD2201200 |
| Eferox |
| EINECS 200-101-1 |
| EINECS 200-221-4 |
| eltroxin |
| Eltroxin (TN) |
| Epitope ID:123889 |
| Epitope ID:136776 |
| Euthyrox |
| Euthyrox (TN) |
| Eutirox |
| Eutirox (TN) |
| Forthyron |
| Forthyron (TN) |
| FT-0600821 |
| FT-0628030 |
| FT-0658959 |
| GP9966 |
| GTPL2635 |
| Henning |
| Henning Sodium |
| HMS1569A08 |
| HMS1921I06 |
| HMS2090P18 |
| HMS2092K12 |
| HMS2096A08 |
| HMS2233J18 |
| HMS3259M11 |
| HSDB 3108 |
| HY-18341 |
| I14-8105 |
| J-524276 |
| J10324 |
| KB-53412 |
| KBio1_001911 |
| KBio2_001556 |
| KBio2_004124 |
| KBio2_006692 |
| KBio3_001642 |
| KBioGR_000516 |
| KBioSS_001556 |
| KS-00000F9R |
| KS-00000HDI |
| L-3,5,3',5'-Tetraiodothyronine |
| L-T4 |
| L-T4 Sodium |
| L-Thryoxin |
| L-Thyroxin |
| L-Thyroxin Sodium |
| L-thyroxine |
| L-Thyroxine (T4) solution, 100 mug/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material |
| L-thyroxine (TN) |
| l-Thyroxine monosodium salt |
| L-Thyroxine sodium |
| L-Thyroxine sodium salt |
| L-Thyroxine, >=98% (HPLC) |
| L-Thyroxine, free acid |
| L-Thyroxine, powder, BioReagent, suitable for cell culture |
| L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo- |
| L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt |
| L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate (9CI) |
| L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1) |
| Laevothyroxinum |
| Laevothyroxinum (acid) |
| Laevoxin |
| Letter |
| Levaxin |
| Levaxin (TN) |
| Leventa |
| Levolet |
| Levoroxine |
| levothroid |
| Levothroid (*Sodium salt*) |
| Levothroid (*Sodiumsalt*) |
| Levothyrox |
| Levothyroxin |
| levothyroxin natrium |
| Levothyroxin-natrium |
| levothyroxine |
| Levothyroxine (BAN) |
| Levothyroxine [INN] |
| Levothyroxine sodique |
| Levothyroxine sodique [INN-French] |
| Levothyroxine sodium |
| Levothyroxine Sodium (anhydrous) |
| Levothyroxine Sodium (L-thyroxine) |
| Levothyroxine Sodium [USAN:INN] |
| Levothyroxine Sodium [USAN] |
| Levothyroxine sodium anhydrous |
| levothyroxine sodium pentahydrate |
| Levothyroxine sodium tablets |
| Levothyroxine, pharmaceutical secondary standard; traceable to USP, PhEur |
| Levothyroxine, United States Pharmacopeia (USP) Reference Standard |
| Levothyroxinum |
| Levothyroxinum (acid) |
| Levothyroxinum natricum |
| Levothyroxinum natricum [INN-Latin] |
| levotiroxina de sodio |
| Levotiroxina sodica |
| Levotiroxina sodica [INN-Spanish] |
| Levoxyl |
| Levoxyl (TN) |
| LS-153817 |
| LS-153822 |
| LS-158291 |
| LT00440967 |
| LT4 |
| MFCD00002595 |
| MLS000028647 |
| MLS002548901 |
| MolPort-002-511-861 |
| MolPort-003-666-820 |
| Monosodium L-thyroxine |
| NC00485 |
| NCGC00094852-03 |
| NCGC00164336-01 |
| NCGC00164336-02 |
| NCGC00164336-03 |
| NCGC00164336-05 |
| NCGC00255368-01 |
| Novothyrox |
| NSC 259940 |
| NSC 36397 |
| NSC 36397-Sodium |
| NSC-757434 |
| NSC757434 |
| O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine |
| O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine |
| O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine Sodium |
| O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine |
| Oroxine |
| Pharmakon1600-01500774 |
| Prestwick_548 |
| Prestwick0_000403 |
| Prestwick1_000403 |
| Prestwick2_000403 |
| Prestwick3_000403 |
| Q51BO43MG4 |
| RL03895 |
| RL04067 |
| Ro-thyroxine |
| Roxstan |
| s2599 |
| SAM002264651 |
| SBI-0051608.P002 |
| SCHEMBL23098 |
| SCHEMBL34102 |
| SDCCGMLS-0066571.P001 |
| SMR000059176 |
| sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate |
| sodium (2S)-2-azanyl-3-[4-[3,5-bis(iodanyl)-4-oxidanyl-phenoxy]-3,5-bis(iodanyl)phenyl]propanoate |
| Sodium (S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionate |
| sodium 4-o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine |
| Sodium l-thyroxin |
| Sodium L-thyroxine |
| Sodium levothyroxine |
| SODIUM LEVOTHYROXINE(1-) |
| Sodium thyroxin |
| Sodium thyroxinate |
| Sodium thyroxine |
| Sodium-L-thyroxine |
| Sodiumlevothyroxine |
| Soloxine |
| SPBio_000386 |
| SPBio_002265 |
| SpecPlus_000871 |
| Spectrum_001076 |
| SPECTRUM1500774 |
| Spectrum2_000573 |
| Spectrum3_000611 |
| Spectrum4_000128 |
| Spectrum5_001500 |
| ST078859 |
| ST24047479 |
| STOCK1N-15023 |
| synthroid |
| Synthroid (*Sodium salt*) |
| Synthroid (TN) |
| Synthroid sodium |
| T-3850 |
| t4 |
| T4 (Hormone) |
| T4 levothyroxine |
| T4 Sodium |
| T44 |
| Tetraiodothyronine |
| Tetramet |
| Tetroid |
| Thevier |
| Thryroxine, l- |
| THX |
| Thyradin |
| Thyradin S |
| Thyratabs |
| Thyrax |
| Thyrax (TN) |
| Thyrax Sodium |
| Thyreoideum |
| Thyreoideum Sodium |
| Thyro-Tabs |
| THYROID |
| Thyronamin |
| Thyrosit |
| Thyrox (TN) |
| Thyroxevan |
| thyroxin |
| Thyroxin sodium |
| Thyroxinal |
| Thyroxinal Sodium |
| thyroxine |
| Thyroxine (l) |
| Thyroxine (T4), IRMM(R) certified Reference Material |
| Thyroxine (VAN) |
| Thyroxine [BAN] |
| Thyroxine I 125 |
| Thyroxine iodine |
| Thyroxine sodique |
| Thyroxine sodium |
| Thyroxine sodium salt |
| Thyroxine, L- |
| Thyroxine, L- (8CI) |
| Thyroxine, L-(8CI) |
| Thyroxine, labeled with iodine-125 |
| Thyroxine, monosodium salt, L- |
| Thyroxinique |
| Thyroxinum natricum |
| Tiroidina |
| Tirosint |
| Tirosint-Sol |
| Tox21_112101 |
| Tox21_112101_1 |
| Tox21_302156 |
| TR-031344 |
| Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-125 |
| Tyrosint |
| UNII-054I36CPMN |
| UNII-7U4LEE5872 |
| UNII-Q51BO43MG4 |
| UNII-QR0BV3BRIA component XUIIKFGFIJCVMT-LBPRGKRZSA-N |
| Unithroid |
| XUIIKFGFIJCVMT-LBPRGKRZSA-N |
| YDTFRJLNMPSCFM-YDALLXLXSA-M |
| Z2798529463 |
| ZINC3830993 |
US Patents and Regulatory Information for LEVO-T
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-001 | Mar 1, 2002 | AB1,AB2,AB3 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-007 | Mar 1, 2002 | AB1,AB2,AB3 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-004 | Mar 1, 2002 | AB1,AB2,AB3 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-011 | Mar 1, 2002 | AB1,AB2,AB3 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
International Patents for LEVO-T
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Canada | 2404369 | ➤ Try a Free Trial |
| Brazil | 0109736 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 0174448 | ➤ Try a Free Trial |
| European Patent Office | 1267999 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
